4 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Prexton Therapeutics Funding History

Since Prexton Therapeutics was founded in 2012, it has participated in 3 rounds of funding. In total Prexton Therapeutics has raised $72.8M. Prexton Therapeutics' last funding round was on Jan 2018 for a total of $31.6M.

Prexton Therapeutics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Series B
Jan 2018
$31.6M
5
Forbion Capital Partners,  Seroba Life Sciences,  Merck Ventures,  Ysios Capital,  Sunstone Capital
Series B
Feb 2017
$31.2M
5
Forbion Capital Partners,  Seroba Life Sciences,  Merck Ventures,  Ysios Capital,  Sunstone Capital
Series A
Feb 2015
$10M
3
Sunstone Capital,  Ysios Capital,  MS Ventures

Total Funding: $72.8M

Prexton Therapeutics Investors

Unlock 3 more investors →

INVESTOR

ROUND

FUNDING DATE

Forbion Capital Partners
Series B
Jan 2018, Feb 2017
Seroba Life Sciences
Series B
Jan 2018, Feb 2017
Merck Ventures
Series B
Jan 2018, Feb 2017
Ysios Capital
Series B, Series A
Jan 2018, Feb 2017, Feb 2015
Sunstone Capital
Series B, Series A
Jan 2018, Feb 2017, Feb 2015

Total Investors: 6

Prexton Therapeutics has 6 investors, including Forbion Capital Partners, Seroba Life Sciences and Merck Ventures. The latest investment occurred in Jan 2018.